0 items USD 0.00Search
Your search for "global markets direct chronic kidney disease chronic renal failure pipeline review h1 2014" gave back 957 results.
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
India In-Vitro Diagnostics (IVD) market is likely to exceed US$ 1.8 Billion mark by 2025. The IVD industry in India has been witnessing immense...
Catalog:
iGATE
April 2019
Price: USD 1,590.00
The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new...
Catalog:
iGATE
September 2016
Price: USD 1,100.00
The Indian pharma industry has always been a leading industrial sector in the country, with a paralleled dominance of both domestic and foreign...
Catalog:
RNCOS
June 2022
Price: USD 900.00
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are...
Catalog:
iGATE
August 2016
Price: USD 1,490.00
The global hearing aids market is anticipated to grow at a CAGR of around 5% during the period 2017 - 2022. The growing prevalence of hearing...
Catalog:
iGATE
January 2017
Price: USD 1,450.00
India is the world's 2nd largest producer of vegetables in the world next only to China. But the fruit and vegetable processing industry in India...
Catalog:
NOVONOUS
June 2016
Price: USD 2,500.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Dr. Reddy’s Laboratories is an India based multinational...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
This latest Research by Study provides critical analysis of various retail opportunities churning out of online-offline convergence and business...
Catalog:
MRRPB3
June 2018
Price: USD 2,495.00
With growing purchasing power and changing lifestyle of Indian consumers, retail industry in India is poised for exponential growth in the next 10...
Catalog:
MRRPB3
June 2018
Price: USD 3,495.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
